New MRI technique could sharpen brain tumor biopsies
NCT ID NCT03458676
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study at MD Anderson Cancer Center tests whether advanced MRI (AMRI) can help doctors better target brain tumor biopsies. About 62 adults with brain lesions will get an AMRI scan before standard surgery. Researchers compare biopsy results from AMRI-guided spots to those from conventional imaging to see if AMRI improves accuracy. The goal is to refine how images guide biopsies for more precise diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors target brain tumor biopsies, leading to more accurate diagnoses.
- What could go wrong
- This is an early-stage study with only 62 participants, so results may not apply broadly. The advanced MRI is not FDA-approved and is used only for research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Childhood brain tumor survivors face hidden hormone risks years later
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?